Pub Date : 2020-01-01DOI: 10.13312/j.issn.1671-7783.y2200033
Yueying Wang
People infected with new coronavirus (severe acute respiratory syndrome coronavirus 2, SARS-CoV-2) usually have respiratory symptoms as their typical manifestations. With the increase in the number of infections, studies have found that the prognosis of patients with cardiovascular disease is more serious than that of ordinary patients. Some patients have viral infection-related heart damage, which may be related to angiotensin-converting enzyme 2 (ACE2)-mediated SARS-CoV-2 infection. Appropriate application of myocardial protective drugs may help improve the prognosis of SARS-CoV-2 infection.
{"title":"Heart damage related to new Coronavirus infection","authors":"Yueying Wang","doi":"10.13312/j.issn.1671-7783.y2200033","DOIUrl":"https://doi.org/10.13312/j.issn.1671-7783.y2200033","url":null,"abstract":"People infected with new coronavirus (severe acute respiratory syndrome coronavirus 2, SARS-CoV-2) usually have respiratory symptoms as their typical manifestations. With the increase in the number of infections, studies have found that the prognosis of patients with cardiovascular disease is more serious than that of ordinary patients. Some patients have viral infection-related heart damage, which may be related to angiotensin-converting enzyme 2 (ACE2)-mediated SARS-CoV-2 infection. Appropriate application of myocardial protective drugs may help improve the prognosis of SARS-CoV-2 infection.","PeriodicalId":16157,"journal":{"name":"Journal of Jiangsu University","volume":"57 1","pages":"93-97"},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82273691","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-01-01DOI: 10.13312/j.issn.1671-7783.y200088
Kai Fu
Since December 2019, a series of unexplained pneumonia cases have been reported in Hubei Province, China. Scientists have isolated a new type of coronavirus (severe acute respiratory syndrome coronavirus 2, SARS-CoV-2), which has been infected by the virus. The epidemic in China and many countries around the world has attracted global attention. This is the third type of coronavirus discovered after the severe acute respiratory syndrome coronavirus (SARS-CoV) and the Middle East respiratory syndrome coronavirus (MERS-CoV). At present, many scholars have conducted a lot of research on it. This article focuses on SARS-CoV. The etiology, epidemiological characteristics, clinical manifestations, imaging examinations, laboratory examinations, diagnosis and treatment of CoV-2 are reviewed.
{"title":"Research progress of novel Coronavirus pneumonia","authors":"Kai Fu","doi":"10.13312/j.issn.1671-7783.y200088","DOIUrl":"https://doi.org/10.13312/j.issn.1671-7783.y200088","url":null,"abstract":"Since December 2019, a series of unexplained pneumonia cases have been reported in Hubei Province, China. Scientists have isolated a new type of coronavirus (severe acute respiratory syndrome coronavirus 2, SARS-CoV-2), which has been infected by the virus. The epidemic in China and many countries around the world has attracted global attention. This is the third type of coronavirus discovered after the severe acute respiratory syndrome coronavirus (SARS-CoV) and the Middle East respiratory syndrome coronavirus (MERS-CoV). At present, many scholars have conducted a lot of research on it. This article focuses on SARS-CoV. The etiology, epidemiological characteristics, clinical manifestations, imaging examinations, laboratory examinations, diagnosis and treatment of CoV-2 are reviewed.","PeriodicalId":16157,"journal":{"name":"Journal of Jiangsu University","volume":"42 1","pages":"101-108"},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81991152","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-01-01DOI: 10.13312/j.issn.1671-7783.y200107
J. Yin, Yang Tang
Objective: To investigate the drug of Bacillus licheniformis Capsule (BLC) to improve the high levels of cytokines and clinical prognosis in COVID-19 patients, and to provide the clinical evidence for gut microflora therapy in COVID-19.
{"title":"Effect of Bacillus licheniformis capsule on the cytokines level and clinical prognosis of COVID-19 patients","authors":"J. Yin, Yang Tang","doi":"10.13312/j.issn.1671-7783.y200107","DOIUrl":"https://doi.org/10.13312/j.issn.1671-7783.y200107","url":null,"abstract":"Objective: To investigate the drug of Bacillus licheniformis Capsule (BLC) to improve the high levels of cytokines and clinical prognosis in COVID-19 patients, and to provide the clinical evidence for gut microflora therapy in COVID-19.","PeriodicalId":16157,"journal":{"name":"Journal of Jiangsu University","volume":"12 1","pages":"451-454"},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89748830","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：